73243-67-1

Basic information

• Product Name: (2R,3R,4R,5S)-2-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4,5-triol
• Synonyms: 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-1-(3-phenylpropyl)-, (2R,3R,4R,5S)-
• CAS NO: 73243-67-1
• Molecular Formula: C₁₅H₂₃NO₄
• Molecular Weight: 281.3474
• Mol File: 73243-67-1.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 493.8°C at 760 mmHg
• Flash Point: 276.3°C
• Density: 1.268g/cm³
• Vapor Pressure: 1.44E-10mmHg at 25°C
• Refractive Index: 1.601
• CAS DataBase Reference: (2R,3R,4R,5S)-2-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4,5-triol(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3R,4R,5S)-2-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4,5-triol(73243-67-1)
• EPA Substance Registry System: (2R,3R,4R,5S)-2-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4,5-triol(73243-67-1)

Safety Data

• Hazardous Substances Data: 73243-67-1(Hazardous Substances Data)

Usage

General Description

(2R,3R,4R,5S)-2-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4,5-triol is a chemical compound with a piperidine structure and three hydroxyl groups. Its molecular formula is C16H23NO4. It is a chiral compound with four stereocenters, indicating that it can exist in multiple stereoisomeric forms. The compound contains a hydroxymethyl group, a phenylpropyl group, and three hydroxyl groups attached to the piperidine ring. (2R,3R,4R,5S)-2-(hydroxymethyl)-1-(3-phenylpropyl)piperidine-3,4,5-triol may have potential applications in medicine, biochemistry, or organic synthesis due to its unique structure and chirality.

Upstream product

• 69567-11-9 2,3,4,6-tetra-O-benzyl-1,5-dideoxy-1,5-imino-D-glucitol 
• 77174-08-4 (3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)piperidin-2-one 
• 14233-48-8 2,3,4,6-tetra-O-benzyl-D-glucitol 

Relevant articles and documents

Design, synthesis, and preliminary immunopotentiating activity of new analogues of nojirimycin

Three new classes of nojirimycin analogues viz. N-alkyl with C1-substituent (4-phenylbutyl), N-substituted 1-deoxynojirimycin and its congener δ-lactam, and a 4-phenylbutyl-β-C-glycoside were designed and synthesized for immunological studies. The resulti

Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections

Provided are methods and compositions for treating hepatitis virus infections in mammals, especially humans. The methods comprise (1) administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, mixtures thereof, or immunomodulating/immunostimulating agents, or (2) administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, or mixtures thereof, and immunomodulating/immuno-stimulating agents.

Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections

Provided are methods and compositions for treating hepatitis virus infections in mammals, especially humans. The methods comprise (1) administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, mixtures thereof, or immunomodulating/immunostimulating agents, or (2) administering N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds alone or in combination with nucleoside antiviral agents, nucleotide antiviral agents, or mixtures thereof, and immunomodulating/immuno-stimulating agents.